These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8742935)

  • 1. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
    Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD
    J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state characterization of E2101, a novel antispastic drug.
    Kushida I; Ashizawa K
    J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.
    Sieger P; Werthmann U; Saouane S
    Eur J Pharm Sci; 2023 Jul; 186():106447. PubMed ID: 37044200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of roxifiban.
    Maurin MB; Vickery RD; Rabel SR; Rowe SM; Everlof JG; Nemeth GA; Campbell GC; Foris CM
    J Pharm Sci; 2002 Dec; 91(12):2599-604. PubMed ID: 12434404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of 1,2-dihydro-6-neopentyl-2-oxonicotinic acid: characterization, interconversion, and quantitation.
    Chao RS; Vail KC
    Pharm Res; 1987 Oct; 4(5):429-32. PubMed ID: 3508554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of spray-dried phenylbutazone polymorphs.
    Matsuda Y; Kawaguchi S; Kobayashi H; Nishijo J
    J Pharm Sci; 1984 Feb; 73(2):173-9. PubMed ID: 6707878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
    Li Y; Chow PS; Tan RB
    Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a novel polymorph of indiplon, Form α.
    Xu L; Wang J; Xiao B; Yang J; Liu Y; Huang R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):963-8. PubMed ID: 22209207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of retinoic acid polymorphism.
    Caviglioli G; Pani M; Gatti P; Parodi B; Cafaggi S; Bignardi G
    J Pharm Sci; 2006 Oct; 95(10):2207-21. PubMed ID: 16883553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism and thermodynamics of m-hydroxybenzoic acid.
    Nordström FL; Rasmuson AC
    Eur J Pharm Sci; 2006 Aug; 28(5):377-84. PubMed ID: 16781127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of glybuzole polymorphs and their pharmaceutical properties.
    Otsuka M; Ofusa T; Matsuda Y
    Drug Dev Ind Pharm; 1999 Feb; 25(2):197-203. PubMed ID: 10065353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermally-prepared polymorphic forms of cilostazol.
    Stowell GW; Behme RJ; Denton SM; Pfeiffer I; Sancilio FD; Whittall LB; Whittle RR
    J Pharm Sci; 2002 Dec; 91(12):2481-8. PubMed ID: 12434391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and Thermodynamic Relationship of Three Polymorphs of a Xanthine Oxidase Inhibitor, Febuxostat.
    Patel J; Jagia M; Bansal AK; Patel S
    J Pharm Sci; 2015 Nov; 104(11):3722-3730. PubMed ID: 26178598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of polymorphism of gepirone hydrochloride.
    Behme RJ; Brooke D; Farney RF; Kensler TT
    J Pharm Sci; 1985 Oct; 74(10):1041-6. PubMed ID: 4078700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic Stability Analysis of Tolbutamide Polymorphs and Solubility in Organic Solvents.
    Svärd M; Valavi M; Khamar D; Kuhs M; Rasmuson ÅC
    J Pharm Sci; 2016 Jun; 105(6):1901-1906. PubMed ID: 27238487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.